Related Experiment Video
Updated: Mar 18, 2026

Experimental Metastasis Assay
Published on: August 24, 2010
Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection
Rebecca A Rosero1, Gabriel J Villares1, Menashe Bar-Eli2
1Biology Department, University of St. Thomas, Houston TX, USA.
Abstract:
The vast array of G-protein-coupled receptors (GPCRs) play crucial roles in both physiological and pathological processes, including vision, coagulation, inflammation, autophagy, and cell proliferation. GPCRs also affect processes that augment cell proliferation and metastases in many cancers including melanoma. Melanoma is the deadliest form of skin cancer, yet limited therapeutic modalities are available to patients with metastatic melanoma. Studies have found that both chemokine receptors and protease-activated receptors, both of which are GPCRs, are central to the metastatic melanoma phenotype and may serve as potential targets in novel therapies against melanoma and other cancers.
Insights
G-protein-coupled receptors (GPCRs) are vital in cancer progression. Targeting specific GPCRs like chemokine and protease-activated receptors shows promise for treating metastatic melanoma.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Background:
- G-protein-coupled receptors (GPCRs) are integral to numerous physiological and pathological processes.
- GPCRs influence cell proliferation and metastasis in various cancers, including melanoma.
- Melanoma, a deadly skin cancer, has limited treatment options for metastatic stages.
Purpose of the Study:
- To investigate the role of GPCRs in melanoma metastasis.
- To identify specific GPCRs as potential therapeutic targets for metastatic melanoma.
Main Methods:
- Literature review of GPCRs in cancer biology.
- Analysis of studies focusing on chemokine receptors and protease-activated receptors in melanoma.
Main Results:
- GPCRs significantly impact cancer cell proliferation and metastasis.
- Chemokine receptors and protease-activated receptors are key players in the metastatic melanoma phenotype.
Conclusions:
- Specific GPCRs, including chemokine and protease-activated receptors, are critical for melanoma metastasis.
- These GPCRs represent promising therapeutic targets for novel anti-melanoma treatments.
Related Concept Videos
G-protein Coupled Receptors
G-protein Coupled Receptors
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G Protein-coupled Receptors

